Abiopharma

🔍 Clark Michael Aaron (Executive)

Company: Contango Silver & Gold Inc. (CTGO)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 16,200 shares of Common Stock, par value $0.01 (Direct)
  Date: 2026-04-02 | Code: A | equity_swap_involved: false | shares_owned_after: 55,998.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 27,500 shares of Stock Option (right to buy) at $18.55 per share (Derivative)
  Date: 2026-04-02 | Code: A | Expires: 2026-04-02 | equity_swap_involved: false | shares_owned_after: 27,500.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: On April 2, 2026, the reporting person was granted 16,200 shares of restricted stock, which vest equally over two years with half vesting on April 2, 2027 and the remaining half vesting on April 3, 2028.
• F2: On April 2, 2026, the reporting person was granted 27,500 stock options that over two years with half vesting on April 2, 2027 and the remaining half vesting on April 3, 2028.